QT
IMUX icon

Quantamental Technologies’s Immunic IMUX Stock Holding History

Quantamental Technologies’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-100
Closed -$10K – 854
2019
Q3 		$10K Buy
100
+20
+25% +$2.68K ﹤0.01% 1318
2019
Q2 		$9K Buy
80
+73
+1,043% +$9.59K ﹤0.01% 1258
2019
Q1 		$1K Hold
7
– – ﹤0.01% 1413
2018
Q4 		$1K Buy
+7
New +$820 ﹤0.01% 1297

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Quantamental Technologies's IMUX Position: Q4 2019 in Review

Quantamental Technologies sold out of Immunic (IMUX) in Q4 2019, closing a stake of 100 shares — an estimated $10K sold.

Quantamental Technologies first reported a position in IMUX in Q4 2018 and held it in 4 quarters. The position peaked at $10K in Q3 2019. 20 funds tracked by Wall St. Rank hold IMUX as of Q4 2019.

  • Quantamental Technologies reported no remaining Immunic position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 100 Immunic shares in Q4 2019, an estimated $10K.
  • Quantamental Technologies first reported a position in Immunic in Q4 2018 and held it in 4 quarters.
  • Quantamental Technologies's Immunic position peaked at $10K in Q3 2019.
  • 20 funds tracked by Wall St. Rank held Immunic as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.